Percutaneously adminstrable preparations containing cerebral function activators
AssigneeShionogi & Co., Ltd.
InventorsKatsuji Sugita, Yoshitaka Nishihara, Takayoshi Yoshikawa
Life of this patent
Estimating the term…
Abstract
The present invention provides a percutaneously administrable preparation comprising either an aqueous base comprising 1-menthol, a lower alcohol and an acidic buffer or water, or an oily base comprising 1-menthol, a lower alcohol and isopropyl myristate, and a cerebral function activator, for example, 2-(3-isoxazolyl)-3,6,7,9-tetrahydroimidazo[4,5-d]pyrano[4,3-b]pyridine, pharmaceutically acceptable salt or hydrate thereof.
Claims2
A percutaneously administrable preparation which comprises 2-(3-isoxazolyl)-3,6,7,9-tetrahydroimidazo[4,5-d]pyrano[4,3-b]pyridine, pharmaceutically acceptable salt or hydrate thereof and an aqueous base wherein 1-menthol is 2 to 3% by weight, ethanol is 20 to 30% by weight, a phosphate buffer wherein pH is 3 to 5 is 60 to 80% by weight, each percentage being with respect to the total amount of the base.
Dependencies are inferred from the claim text.